Clinical Trial Update: Urinary G3BP as a Novel Biomarker in Lupus Nephritis

View source ↗

Summary

This clinical trial update investigates urinary G3BP as a novel biomarker for lupus nephritis and indicates the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Snippet

Sponsor: Assiut University | Conditions: Lupus Nephritis | Status: NOT_YET_RECRUITING